Who invested in Rebound Therapeutics?
Rebound Therapeutics's investors include Invus.
One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$17Mraised across 1 round since 2017, from 1 source
Rebound Therapeutics's investors include Invus.
Rebound Therapeutics has raised $17M across 1 round since 2017.
Rebound Therapeutics's most recent round was a Series B of $17M in Jul 2017.
Its most recent round, $17M in Jul 2017, is also its largest on record.
Rebound Therapeutics's first round on record, in Jul 2017, was backed by Invus.
Rebound Therapeutics's latest named round is a Series B, in Jul 2017.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.